
-
Kenya's economy faces climate change risks: World Bank
-
French PM's daughter says priest beat her as a teenager
-
WEF confirms investigation into claims against founder Schwab
-
At night, crime and fear stalk DR Congo's M23-run areas
-
Coral reefs pushed to brink as bleaching crisis worsens
-
Veteran Chinese astronaut to lead fresh crew to space station
-
Tokyo's newest art star: one-year-old Thumbelina
-
Climate watchers fret over Trump's cut to sciences
-
'Everyday attack' - Trans youth coming of age in Trump's America
-
Auto Shanghai showcases new EV era despite tariff speedbumps
-
Musk to reduce White House role as Tesla profits plunge
-
Tesla says profits plunge 71%, warns of 'changing political sentiment'
-
Gunmen kill dozens of civilians in Kashmir tourist hotspot
-
US Treasury chief expects China tariff impasse to de-escalate
-
Volkswagen unveils its electric counter-offensive in China
-
ECB's Lagarde hopes Trump won't fire US Fed chief Powell
-
Gold hits record as Trump fuels Fed fears, Wall Street rebounds
-
IMF slashes global growth outlook on impact of Trump tariffs
-
Nordics, Lithuania plan joint purchase of combat vehicles
-
Gold hits record, stocks diverge as Trump fuels Fed fears
-
IMF slashes China growth forecasts as trade war deepens
-
US VP Vance says 'progress' in India trade talks
-
Roche says will invest $50 bn in US, as tariff war uncertainty swells
-
US official asserts Trump's agenda in tariff-hit Southeast Asia
-
Roche says will invest $50 bn in US over next five years
-
US Supreme Court to hear case against LGBTQ books in schools
-
Global warming is a security threat and armies must adapt: experts
-
Can Europe's richest family turn Paris into a city of football rivals?
-
Climate campaigners praise a cool pope
-
US to impose new duties on solar imports from Southeast Asia
-
Draft NZ law seeks 'biological' definition of man, woman
-
Auto Shanghai to showcase electric competition at sector's new frontier
-
Indonesia food plan risks 'world's largest' deforestation
-
Trump helps enflame anti-LGBTQ feeling from Hungary to Romania
-
Trump tariffs torch chances of meeting with China's Xi
-
X rival Bluesky adds blue checks for trusted accounts
-
China to launch new crewed mission into space this week
-
Latin America fondly farewells its first pontiff
-
US assets slump again as Trump sharpens attack on Fed chief
-
US urges curb of Google's search dominance as AI looms
-
Mourning Americans contrast Trump approach to late Pope Francis
-
China's CATL launches new EV sodium battery
-
Real Madrid hold minute's silence as La Liga mourns Pope Francis
-
Clerical sex abuse: Pope Francis's thorniest challenge
-
Francis: radical leader who broke the papal mould
-
Inside South Africa's wildlife CSI school helping to catch poachers
-
Nigerian Afrobeat legend Femi Kuti takes a look inward
-
Kim Kardashian: From sex tape to Oval Office via TV and Instagram
-
Vance heads to India for tough talks on trade
-
Gold hits record, dollar drops as tariff fears dampen sentiment

Morocco starts construction of anti-Covid vaccine plant
Morocco on Thursday inaugurated construction of an anti-Covid vaccine manufacturing plant in partnership with Swedish firm Recipharm, the official news agency MAP reported.
The factory to be known as Sensyo Pharmatech will produce vaccines against coronavirus and other diseases, with production expected to reach 116 million units in 2024, MAP said.
It was launched in Benslimane, a region of Morocco's economic hub Casablanca during a ceremony attended by King Mohammed VI, it said.
The plant will need investments of between 400-500 million euros ($445 million-$557 million).
It is aimed at ensuring vaccine "self-sufficiency" for the North African kingdom, MAP said.
Its goal is to make, between 2022 and 2025, "active substances for more than 20 vaccines, three of which would be against coronavirus... to cover 70 percent of the kingdom's needs and more than 60 percent of needs across Africa", the agency said.
Morocco is already producing the Chinese anti-Covid Sinopharm vaccine, with more than three million doses being made per month.
By next month it plans on producing five million doses and more than 20 million by the end of the year.
Home to 36 million inhabitants, Morocco is hoping that its vaccination drive will help eradicate Covid-19. More than 23 million people have already received a second dose against coronavirus, according to the health ministry.
Authorities hope to vaccinate 80 percent of the population with either Sinopharm or Pfizer-BioNTech.
In July, Recipharm said it had signed a memorandum of understanding with Morocco and a consortium of the country's leading banks to build a factory to produce vaccines and biotherapeutics in the kingdom.
As part of the deal, it said in a statement at the time, $500 million would be invested into the project by the Moroccan government and consortium.
"The investment is primarily to supply the African continent and help it gain vaccine sovereignty and access to future biotherapeutics," it said.
Y.Uduike--CPN